Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 286-272-3 | CAS number: 85203-81-2
Endpoint summary
Administrative data
Description of key information
The LD50 of Hexanoic acid, 2-ethyl-, zinc salt, basic via oral and dermal route is >2000mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Acute oral toxicity:
One reliable in vivo study described by Pels Rijcken (1995) (OECD 401; GLP compliant) is considered to be reliable without restrictions. The oral LD50 in rats was determined to be >2000mg/kg bw.
Acute dermal toxicity:
One reliable in vivo study described by Pels Rijcken (1995) (OECD 402; GLP compliant) is considered to be reliable without restrictions. The dermal LD50 in rats was determined to be >2000mg/kg bw.
Information on the acute toxicity of the individual constituents of hexanoic acid, 2 -ethyl-, zinc salt, basic is reported as supporting information, clearly showing that both constituents zinc and 2 -ethylhexanoic acid are void of acute toxic effects whatsoever.
Justification for classification or non-classification
The oral and dermal LD50 for hexanoic acid, 2-ethyl-, zinc salt, basic is > 2000mg/kg, hence the substance is not to be classified according to regulation (EC) 1272/2008 for acute oral and dermal toxicity as well as for specific target organ toxicity, single exposure (STOT SE).
Furthermore, according to Directive 67/548 EC, a classification and labelling for acute oral and dermal toxicity of hexanoic acid, 2-ethyl-, zinc salt, basic
is not required.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
